Financing, Equity Private Placements

CereVasc, Inc.

05/24
|
$70.0 Million
CereVasc
Bain
Xontogeny
Piper Sandler served as sole financial advisor for CereVasc, Inc. on a Series B Financing from Bain Capital Life Sciences and Perceptive Xontogeny Venture Fund (PXV)
Sub-Type
Minority Capital Raise
Sector
Healthcare
Sub-Sector
Med-Tech

Related Transactions

All Transactions
$40.7 Million
Chain Bridge
Chain Bridge Bancorp
IPO
Active Bookrunner
$77.7 Million
eagle bank
Eagle Bancorp, Inc.
Fixed Rate Senior Notes
Sole Placement Agent
$150.0 Million
EverBank
EverBank Financial Corp.
Subordinated Notes Offering
Sole Underwriter
Northpointe
Northpointe Bancshares, Inc.
Subordinated Notes Offering
Sole Placement Agent
miax
warburg pincus
Miami International Holdings, Inc.
Miami International Holdings, Inc received a strategic growth investment from Warburg Pincus
Financial Advisor
$42.0 Million
Trinitas
Trinitas Capital Management, LLC
Senior Unsecured Notes Offering
Sole Placement Agent
$103.2 Million
Merchants Bancorp
Merchants Bancorp
Confidentially Marketed Follow-On Offering
Passive Bookrunner
$70.0 Million
CereVasc
Bain
Xontogeny
CereVasc, Inc.
CereVasc, Inc. has received a Series B Financing from Bain Capital Life Sciences and Perceptive Xontogeny Venture Fund (PXV)

Financial Advisor
$225.0 Million
Provident Financial Services, Inc.
Provident Financial Services Inc.
Subordinated Notes Offering
Left Bookrunner
$184.7 Million
Skyward Specialty Insurance
Skyward Specialty Insurance
Follow-On Offering
Passive Bookrunner
$100.0 Million
Context Therapeutics LLC
Context Therapeutics LLC
PIPE
Sole Placement Agent
$50.0 Million
Legion
Riverwood
Legion Technologies, Inc.
Legion Technologies, Inc. has received a growth investment from Riverwood Capital Management L.P.
Financial Advisor
$201.2 Million
Nurix Inc.
Nurix Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$150.0 Million
Blue Ridge Bankshares
Blue Ridge Bankshares, Inc.
PIPE
Sole Placement Agent
$200.0 Million
Praxis Precision Medicines
Praxis Precision Medicines, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$100.0 Million
Boundless Bio, Inc.
Boundless Bio, Inc.
Initial Public Offering
Active Bookrunner

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.